 mechan hyperglycemia type II mellitu therapeut implic sulfonylurea treatment updat non-insulin-depend diabet niddm hyperglycemia defect pancreat islet liver peripher tissu feedback loop respons mainten glucos homeostasi review key role endocrin pancrea alpha beta cell glucos output liver glucos util basal rate hepat glucos util basal rate hepat glucos product subject niddm degre hyperglycemia increas rate glucos releas liver result impair hepat sensit insulin secret glucagon secret basal immunoreact insulin level patient niddm normal healthi individu islet function glucos level impair basal steady-st insulin secret due reduct beta-cel secretori capac reduc abil glucos glucagon degre impair beta-cel respons degre hyperglycemia curvilinear fashion effici glucos uptak peripher tissu impair due combin decreas insulin secret defect cellular insulin action impair import hyperglycemia islet alpha- beta-cel function declin therapeut intervent effect hepat glucos product islet dysfunct plasma insulin level effect insulin liver result declin fast glucos level caus hyperglycemia niddm steady-st re-regul plasma glucos concentr elev level islet dysfunct necessari role treatment physiolog understand